Eliminating Silos: Dismantling the Frankenstein of Clinical R&D

Clinical Informatics News Contributed Commentary In January 2017, there were 4,003 pharmaceutical companies with nearly 15,000 drugs in the pipeline. Yet only 1 in 5 drugs actually make it to market. Technology inherently aims to streamline processes, eliminate manual effort and create efficiencies, but is technology still doing this for clinical research?
 
 
 
 
http://www.clinicalinformaticsnews.com/2018/03/05/eliminating-silos-dismantling-frankenstein-clinical-rnd.aspx

Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis

Novartis has entered into a collaboration with Pear Therapeutics to develop novel prescription digital therapeutics, software applications designed to effectively treat disease and improve clinical outcomes for patients. The collaboration brings together Novartis expertise in biomedical research and clinical development with Pear’s leading experience in digital therapeutics design and implementation. http://www.worldpharmanews.com/novartis/4311-novartis-and-pear-therapeutics-to-develop-digital-therapeutics-for-patients-with-schizophrenia-and-multiple-sclerosis